Recent Bills
- H.R. 10171August 27, 2026
- H.R. 10156August 27, 2026
- H.R. 10172August 27, 2026
- H.R. 10160August 27, 2026
- H.R. 10181August 27, 2026
- H.R. 10176August 27, 2026
- H.Res. 1496August 27, 2026
- H.R. 10164August 27, 2026
- H.R. 10170August 27, 2026
- H.Res. 1494August 27, 2026
- H.R. 10163August 27, 2026
- H.R. 10157August 27, 2026
Committees
- Administration
- Agriculture
- Agriculture, Nutrition, And Forestry
- Appropriations
- Armed Services
- Banking, Housing, And Urban Affairs
- Budget
- Commerce, Science, And Transportation
- Education and Workforce
- Energy And Commerce
- Energy And Natural Resources
- Environment And Public Works
- Ethics
- Finance
- Financial Services
- Foreign Affairs
- Foreign Relations
- Health, Education, Labor, And Pensions
- Homeland Security
- Homeland Security And Governmental Affa…
- Indian Affairs
- Indian and Insular Affairs
- Intelligence
- Judiciary
- Natural Resources
- Oversight And Government Reform
- Permanent Select Intelligence
- Rules
- Rules And Administration
- Science, Space, And Technology
- Select Intelligence
- Small Business
- Small Business And Entrepreneurship
- Subcommittee on Aviation
- Subcommittee on Border Security and Enf…
- Subcommittee on Coast Guard and Maritim…
- Subcommittee on Commodity Markets, Digi…
- Subcommittee on Conservation, Research,…
- Subcommittee on Counterterrorism and In…
- Subcommittee on Cybersecurity and Infra…
- Subcommittee on Disability Assistance a…
- Subcommittee on Economic Development, P…
- Subcommittee on Economic Opportunity
- Subcommittee on Emergency Management an…
- Subcommittee on Energy and Mineral Reso…
- Subcommittee on Federal Lands
- Subcommittee on Forestry and Horticultu…
- Subcommittee on General Farm Commoditie…
- Subcommittee on Health
- Subcommittee on Highways and Transit
- Subcommittee on Livestock, Dairy, and P…
- Subcommittee on Nutrition and Foreign A…
- Subcommittee on Oversight and Investiga…
- Subcommittee on Oversight, Investigatio…
- Subcommittee on Railroads, Pipelines, a…
- Subcommittee on Transportation and Mari…
- Subcommittee on Water Resources and Env…
- Subcommittee on Water, Wildlife and Fis…
- Transportation And Infrastructure
- Veterans' Affairs
- Ways And Means
BILL DAVIS is a registered lobbyist named on 17 federal lobbying filings, 2023 to 2026.
An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.
Firms
2 they have filed under, by filings.
| Registrant | Filings | Reported |
|---|---|---|
| BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 16 | — |
| ZOETIS INC. | 1 | — |
By year
Filings and what they reported, newest year first.
| Year | Filings | Income | Expenses |
|---|---|---|---|
| 2026 | 2 | — | $1.5M |
| 2025 | 6 | — | $5.2M |
| 2024 | 4 | — | $4.5M |
| 2023 | 5 | — | $5.9M |
Issues
The LDA issue codes the filings were filed under.
| Code | Issue | Filings |
|---|---|---|
ANI | Animals | 16 |
BUD | Budget/Appropriations | 16 |
HCR | Health Issues | 16 |
MMM | Medicare/Medicaid | 16 |
TRD | Trade (domestic/foreign) | 4 |
DEF | Defense | 3 |
AGR | Agriculture | 1 |
GOV | Government Issues | 1 |
TAX | Taxation/Internal Revenue Code | 1 |
Bills
The bills the filings name, by how many name them.
| Bill | Title | Filings |
|---|---|---|
| H.R. 1492 | To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi… | 7 |
| H.R. 8467 | ZOMBIE Act | 7 |
| S. 832 | EPIC Act of 2025 | 7 |
| H.R. 1842 | PAW Act of 2025 | 5 |
| H.R. 3419 | To amend the Public Health Service Act to reauthorize the telehealth network and telehealth resource centers… | 4 |
| S. 1666 | Improving Social Security’s Service to Victims of Identity Theft Act | 4 |
| H.R. 842 | Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act | 3 |
| H.R. 946 | ORPHAN Cures Act | 3 |
| S. 1862 | ORPHAN Cures Act | 3 |
| S. 339 | A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early… | 3 |
Filings
The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.
| Client | Registrant | Period | Reported | Posted |
|---|---|---|---|---|
| ZOETIS INC. | ZOETIS INC. | 2026 second_quarter | $300K | Jul 20, 2026 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2026 first_quarter | $1.2M | Apr 20, 2026 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2025 second_quarter | $990K | Mar 10, 2026 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2025 fourth_quarter | $610K | Feb 4, 2026 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2025 fourth_quarter | $580K | Jan 20, 2026 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2025 third_quarter | $820K | Oct 20, 2025 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2025 second_quarter | $990K | Jul 21, 2025 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2025 first_quarter | $1.2M | Apr 21, 2025 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2024 fourth_quarter | $850K | Jan 21, 2025 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2024 third_quarter | $1.2M | Oct 22, 2024 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2024 second_quarter | $1M | Jul 22, 2024 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2024 first_quarter | $1.4M | Apr 22, 2024 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2023 fourth_quarter | $970K | Jan 23, 2024 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2023 third_quarter | $1.2M | Oct 20, 2023 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2023 second_quarter | $890K | Jul 20, 2023 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2023 first_quarter | $1.4M | May 5, 2023 |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | 2023 first_quarter | $1.4M | Apr 20, 2023 |